NCT03590743 - Calf Deep Vein Thrombosis Treatment Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 19, 2019

Primary Completion Date

June 3, 2019

Study Completion Date

June 3, 2019

Conditions

Deep Vein Thrombosis

Interventions

DRUG

Apixaban

Active anticoagulation with apixaban 10 mg twice daily for 7 days followed by 5 mg twice daily to complete a total of 3 months treatment.

OTHER

Placebo

apixaban matching placebo 2 tablets twice daily for 7 days followed by one tablet twice daily to complete a total of 3 months.

Trial Locations (3)

Mayo Clinic, La Crosse

Mayo Clinic, Eau Claire

Mayo Clinic in Rochester, Rochester